Posts tagged Liu v. SEC.
Blogs
3 minute read
On September 30, 2020, the Third Circuit reversed a decision by the Eastern District of Pennsylvania ordering AbbieVie, Inc. (“AbbieVie”) and Besins Healthcare Inc. (“Besins”) to pay $448 million in disgorgement of ill-gotten profits for allegedly filing sham patent lawsuits to stifle competition. AbbieVie and Besins had filed patent infringement lawsuits against two developers of generic alternatives to its brand-name testosterone gel product AndroGel. The FTC sued AbbieVie and Besins in 2014 alleging that the patent suits were baseless and brought for no other ...
Blog Editors
Recent Updates
- Eleventh Circuit Clarifies: Discovery Materials Can Be Used to Meet Rule 9(b)
- Biometric Backlash: The Rising Wave of Litigation Under BIPA and Beyond
- Tasked with Troubling Content: AI Model Training and Workplace Implications
- Extraterritorial Application of the DTSA: Recent Decision Continues to Develop “Act in Furtherance” Element
- Shielding Reproductive Freedom: Uncovering New York’s Law Protecting Providers from Civil and Criminal Liability